Rapalink-1

CAS : 1887095-82-0

Ref. 3D-MAD09582

Informations sur le produit

• Nom: Rapalink-1
• Marque: Biosynth
• Description: Rapalink-1 is a gene therapy drug that has been shown to be effective against resistant mutants of malignant brain tumors. Rapalink-1 is a protein that has been engineered to bind to mesenchymal markers and inhibit the progression of cancer cells. This protein also has the ability to induce autophagy, which can lead to axonal growth and help with ischemia–reperfusion injury in pediatric patients. Rapalink-1 inhibits tumor growth by triggering autophagy, which can lead to axonal growth and help with ischemia–reperfusion injury in pediatric patients. Rapalink-1 is an autophagy inducer that binds to mesenchymal markers on cancer cells and inhibits the progression of cancer cells. It also has the ability to induce autophagy, which can lead to axonal growth and help with ischemia–reperfusion injury in pediatric patients.

Propriétés chimiques

• Masse moléculaire: 1,784.1 g/mol
• Formule: C₉₁H₁₃₈N₁₂O₂₄
• Degré de pureté: Min. 95%